Skip to content
10-Q

Quarterly Report

NASCENT BIOTECH, INC.

0001477932-24-004823

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Aug 14, 2024 172.2M sh
Operating Cash Flow Q1 2025 · Jun 30, 2024 −$324.73K
Operating Cash Flow Q1 2025 · Jun 30, 2023 −$162.71K
Stockholders Equity Q1 2025 · Jun 30, 2024 −$514.54K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$256.67K
Stockholders Equity restated Q1 2025 · Jun 30, 2023 −$1.12M
Stockholders Equity Q1 2025 · Mar 31, 2023 −$1.3M
Current Liabilities Q1 2025 · Jun 30, 2024 $741.93K
Current Liabilities Q1 2025 · Mar 31, 2024 $808.79K
Total Liabilities Q1 2025 · Jun 30, 2024 $741.93K
Total Liabilities Q1 2025 · Mar 31, 2024 $808.79K
Current Assets Q1 2025 · Jun 30, 2024 $227.39K
Current Assets Q1 2025 · Mar 31, 2024 $552.12K
Total Assets Q1 2025 · Jun 30, 2024 $227.39K
Total Assets Q1 2025 · Mar 31, 2024 $552.12K
Rd Expense Q1 2025 · Jun 30, 2024 $15K
Rd Expense Q1 2025 · Jun 30, 2023 $25.91K
Net Income Q1 2025 · Jun 30, 2024 −$377.39K
Net Income Q1 2025 · Jun 30, 2023 −$540.22K
Operating Income Q1 2025 · Jun 30, 2024 −$375.66K
Operating Income Q1 2025 · Jun 30, 2023 −$511.97K